News

On July 16, myMatrixx Chief Clinical Officer Phil Walls will speak to the Kansas Self Insurers Association’s (KSIA) Annual Conference.

myMatrixx Chief Clinical Officer Phil Walls joined John Ruser, PhD, President and CEO of the Workers’ Compensation Research Institute for an on-demand webinar available starting June 24, on the Risk & Insurance website.

The COVID-19 pandemic will continue to have an impact on workers’ compensation pharmacy for the foreseeable future. Recently, myMatrixx Vice President of Business Intelligence, Cliff Belliveau, joined Chief Clinical Officer, Phil Walls, to discuss this new landscape for industry publication Risk & Insurance’s Insights feature.

In a new post for industry publication WorkCompWire, myMatrixx Chief Clinical Officer Phil Walls shares how the COVID-19 pandemic will have a lasting effect on workers’ compensation pharmacy.

On May 26, myMatrixx President and CEO Mike Cirillo joined a panel of industry leaders as part of the National Workers’ Compensation and Disability Conference’s (NWCDC) ongoing Digital Sessions Series.

On May 24, 2021, the New York Workers’ Compensation Board (WCB) Chair delayed the implementation of amendments to the following regulations, which were scheduled to become effective on June 7, 2021...

In an upcoming webcast for the National Workers' Compensation and Disability Conference (NWCDC,) myMatrixx President, Mike Cirillo, will be a featured speaker along with other leaders in the field.

myMatrixx President Mike Cirillo was recently featured in Risk & Insurance discussing why Kids’ Chance of America (KCOA) is such a vital organization for workers’ compensation.

In articles for industry publications WCI Weekly and WorkersCompensation.com, myMatrixx experts highlighted some of the key takeaways from the newly released 2020 Drug Trend Report.

myMatrixx Chief Clinical Officer, Phil Walls, was recently quoted in two separate articles for industry publication Business Insurance.